
Sign up to save your podcasts
Or


The Scientist’s LabTalk is a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research.
In this episode, Niki Spahich from The Scientist’s Creative Services team spoke with Josh Snow, Director of Business Development and Marketing Strategy at Mirus Bio, about the past, present, and future of gene therapy, with a focus on how researchers can transition their successful therapies to clinical trials and the market, and the costs involved.
This episode is brought to you by Mirus Bio. Mirus Bio pioneered scientific breakthroughs in non-viral gene delivery and continues to produce world-class transfection reagents. Now as a global leader in transfection technology, Mirus Bio provides life scientists with the most advanced tools for gene expression, biotherapeutic protein production, virus manufacturing and genome editing.
Welcome to The Scientist’s LabTalk, a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research. This episode is brought to you by Keystone Symposia. Don’t miss their upcoming virtual eSymposia Tuberculosis: Science Aimed at Ending the Epidemic on December 2-4, 2020.
One of the symposium’s co-organizers and keynote speaker is David Alland, Chief of Infectious Disease and Director of the Center for Emerging Pathogens and the Center for COVID-19 Response and Pandemic Preparedness at Rutgers New Jersey Medical School. Niki Spahich from The Scientist’s Creative Services team spoke with Alland about his journey to develop a rapid, point-of-care tuberculosis diagnostic and his current research on mutations that lead to drug resistance.
Welcome to The Scientist’s LabTalk, a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research.
Welcome to The Scientist’s LabTalk, a special edition podcast produced by The Scientist’s Creative Services Team where we explore topics at the leading edge of innovative research. This episode is brought to you by Keystone Symposia. Don’t miss their upcoming virtual eSymposium on myeloid cells and innate immunity in solid tumors on September 21-23, 2020. http://keysym.us/Myeloid21Scientist
One of the eSymposium’s speakers is Miriam Merad, a professor in Cancer immunology and the Director of the Precision Immunology Institute at the Icahn School of Medicine at Mount Sinai. Niki Spahich from The Scientist’s Creative Services team spoke with Merad about her research investigating how antigen presenting cells enhance anti-tumor immune responses, and her recent advocacy work fighting against the foreign scholar visa ban.
From the publisher's feed